This canonical paper page includes Commercialization Proof and Related Resources.
ARXIV:2603.26509 · MEDICAL IMAGING AI · SUBMITTED 30 MAR · 20:30 UTC · FRESHNESS STALE
ARXIV:2603.26509MEDICAL IMAGING AISUBMITTED 30 MAR · 20:30 UTCFRESHNESS STALEMartin Rath · Morteza Ghahremani · Yitong Li · Ashkan Taghipour · Marcus Makowski · Christian Wachinger · arXiv
Revolutionizing diagnostic imaging by reconstructing 3D CT volumes from 2D X-rays, reducing costs and radiation exposure.
Opportunity summary
Pain Revolutionizing diagnostic imaging by reconstructing 3D CT volumes from 2D X-rays, reducing costs and radiation exposure.
Evidence 54 refs | 3 sources | 83% coverage
Blocker Evidence unverified
Revolutionizing diagnostic imaging by reconstructing 3D CT volumes from 2D X-rays, reducing costs and radiation exposure. While standard chest X-rays are cost-effective and widely accessible, they only provide 2D projections with limited pathological information.
Computed tomography (CT) provides rich 3D anatomical details but is often constrained by high radiation exposure, substantial costs, and limited availability. While standard chest X-rays are cost-effective and widely accessible, they only provide 2D…
ScienceToStartup currently rates this 8.0/10 on the public viability pass. It also supports bi-planar X-ray input to mitigate depth ambiguities inherent in 2D-to-3D reconstruction. A public repository is linked, so build verification can inspect…
Medical Imaging AI moved forward this cycle; last verified April 2026. Public score 8.0/10. Implementation evidence is present through a linked repository.
Continue into Read for claims, analysis, references, and neighboring papers.
mobile layout uses overflow-hidden min-w-0 break-wordsOpportunity summary
Score8.0Public score shown from the verified overall while the stale axis breakdown refreshesAnalysis summary
Revolutionizing diagnostic imaging by reconstructing 3D CT volumes from 2D X-rays, reducing costs and radiation exposure.
Loading BUILD…
Paper Pack
10.48550/arXiv.2603.26509Revolutionizing diagnostic imaging by reconstructing 3D CT volumes from 2D X-rays, reducing costs and radiation exposure.
Abstract
Computed tomography (CT) provides rich 3D anatomical details but is often constrained by high radiation exposure, substantial costs, and limited availability. While standard chest X-rays are cost-effective and widely accessible, they only provide 2D projections with limited pathological information. Reconstructing 3D CT volumes from 2D X-rays offers a transformative solution to increase diagnostic accessibility, yet existing methods predominantly rely on synthetic X-ray projections, limiting clinical generalization. In this work, we propose AXON, a multi-stage diffusion-based framework that reconstructs high-fidelity 3D CT volumes directly from real X-rays. AXON employs a coarse-to-fine strategy, with a Brownian Bridge diffusion model-based initial stage for global structural synthesis, followed by a ControlNet-based refinement stage for local intensity optimization. It also supports bi-planar X-ray input to mitigate depth ambiguities inherent in 2D-to-3D reconstruction. A super-resolution network is integrated to upscale the generated volumes to achieve diagnostic-grade resolution. Evaluations on both public and external datasets demonstrate that AXON significantly outperforms state-of-the-art baselines, achieving a 11.9% improvement in PSNR and a 11.0% increase in SSIM with robust generalizability across disparate clinical distributions. Our code is available at https://github.com/ai-med/AXON.
Source availability
PDF linkedThe paper record includes a public PDF URL.
Extraction status
Parse run linkedA document parse run is attached to this paper.
Proof status
unverified54 refs; 3 sources; 83% coverage.
What was readable
Derived fallback: Estimated from adjacent evidence; not verified from source.
Viability
Time to MVP
Commercial
Export
Preparing verified analysis
Dimensions overall score 8.0
PROBLEM
Revolutionizing diagnostic imaging by reconstructing 3D CT volumes from 2D X-rays, reducing costs and radiation exposure. While standard chest X-rays are cost-effective and widely accessible, they only provide 2D projections with limited pathological information.
METHOD
Computed tomography (CT) provides rich 3D anatomical details but is often constrained by high radiation exposure, substantial costs, and limited availability. While standard chest X-rays are cost-effective and widely accessible, they only provide 2D projections with limited path...
RESULT
ScienceToStartup currently rates this 8.0/10 on the public viability pass. It also supports bi-planar X-ray input to mitigate depth ambiguities inherent in 2D-to-3D reconstruction. A public repository is linked, so build verification can inspect implementation evidence instead o...
WHY NOW
Medical Imaging AI moved forward this cycle; last verified April 2026. Public score 8.0/10. Implementation evidence is present through a linked repository.
In this work, we propose AXON, a multi-stage diffusion-based framework that reconstructs high-fidelity 3D CT volumes directly from real X-rays.
This is a core claim stated in the abstract and supported by the overall description of the framework.
partial
AXON employs a coarse-to-fine strategy, with a Brownian Bridge diffusion model-based initial stage for global structural synthesis, followed by a ControlNet-based refinement stage for local intensity optimization.
The abstract explicitly details the two-stage approach and the models used in each stage.
partial
A super-resolution network is integrated to upscale the generated volumes to achieve diagnostic-grade resolution.
The abstract clearly states the inclusion of a super-resolution network for achieving diagnostic-grade resolution.
partial
Evaluations on both public and external datasets demonstrate that AXON significantly outperforms state-of-the-art baselines, achieving a 11.9% improvement in PSNR and a 11.0% increase in SSIM with robust generalizability across disparate clinical distributions.
Specific quantitative results are provided in the abstract, directly comparing AXON to baselines.
partial
Evaluations on both public and external datasets demonstrate that AXON significantly outperforms state-of-the-art baselines, achieving a 11.9% improvement in PSNR and a 11.0% increase in SSIM with robust generalizability across disparate clinical distributions.
The abstract explicitly mentions robust generalizability as a key outcome of the evaluations.
partial
The approach depends on the quality of X-ray input and may be limited by anatomical variability.
This is mentioned as a caveat in the analysis section.
partial
The approach depends on the quality of X-ray input and may be limited by anatomical variability.
This is mentioned as a limitation in the analysis section.
partial
It also supports bi-planar X-ray input to mitigate depth ambiguities inherent in 2D-to-3D reconstruction.
This technical detail is explicitly stated in the abstract as a feature of AXON.
partial
In this work, we propose AXON, a multi-stage diffusion-based framework that reconstructs high-fidelity 3D CT volumes directly from real X-rays.
This is the core assertion of the abstract and the paper's title.
partial
AXON employs a coarse-to-fine strategy, with a Brownian Bridge diffusion model-based initial stage for global structural synthesis, followed by a ControlNet-based refinement stage for local intensity optimization.
The abstract explicitly describes the two-stage approach and the models used in each stage.
partial
A super-resolution network is integrated to upscale the generated volumes to achieve diagnostic-grade resolution.
The abstract clearly states the inclusion of a super-resolution network for achieving diagnostic-grade resolution.
partial
Evaluations on both public and external datasets demonstrate that AXON significantly outperforms state-of-the-art baselines, achieving a 11.9% improvement in PSNR and a 11.0% increase in SSIM with robust generalizability across disparate clinical distributions.
The abstract provides specific quantitative improvements in PSNR and SSIM.
partial
Paper-native neighborhood for concepts, methods, materials, markets, and competitors. Missing lanes stay labeled instead of disappearing behind commercialization gates.
Concepts
Methods
Materials
Markets
Competitors
Revolutionizing diagnostic imaging by reconstructing 3D CT volumes from 2D X-rays, reducing costs and radiation exposure.
Segment
Medical Imaging AI
Adoption evidence
Public code linked for build inspection
Commercial read
8.0/10 public viability
Direct
Adjacent
Substitute
Unknown
No indexed public discussion is attached to 2603.26509 yet. That is a visibility signal, not a blank module: the monitor is watching the public channels below.
Hacker News
Not indexed yet
Not indexed yet
Bluesky
Not indexed yet
Preview the source document here, or use the hero PDF action for a new tab.
Reference metadata is not materialized in the public index yet. The source PDF remains the authority; cache refresh is optional.
CITED BY
No citing papers are indexed in the public S2S graph yet. This is an explicit zero-signal state, not a hidden lookup.
Foundation
Extension
Commercially relevant
Conflicting
Owned Distribution
Get the weekly shortlist of commercializable papers, benchmark movers, and proof receipts that matter for product execution.
3/3 checks · 100%
Build Passport
Build passport pending - Proof Lab budget No verified cost estimate / $7.00 cap
status
missing
reason
passport_row_missing
proof status
unverified
cost/budget
No verified cost estimate
confidence low
next verification path
Build brief missing until Build Passport data exists.
Source missing: Build Passport payload.
Experiment plan missing until prototype path is available.
No prototype path attached.
Validation checklist missing until required assets, cost, and regulatory flags are verified.
No checklist artifact is attached to the Build Passport payload.
Derived signals show verified:false until source-backed receipts exist.
Evidence coverage
OpportunityKernel evidence_receipt
54 refs / 3 sources / 83% coverage
stale
Verify missing sources before using this as buyer proof. verified:false
Build readiness
BuildPassport EvidenceState
passport absent
stale
Run Proof Lab or inspect typed missing state. verified:false
Artifact maturity
GitHub and Hugging Face maturity payloads
No public artifact surface observed
stale
Open source artifacts or mark the gap as missing. verified:false
Technical feasibility
partial
Current read
Runnable path is not fully verified.
Evidence
No Build Passport payload attached.
Gaps
Next test
Run minimal reproduction from the Build Passport prototype path.
Market urgency
partial
Current read
Research evidence exists; buyer urgency still needs source proof.
Evidence
54 references, 3 sources, 83% evidence coverage.
Gaps
Next test
Collect buyer interview, deployment evidence, or cited demand signal.
Buyer clarity
missing
Current read
No budget owner is verified for this paper.
Evidence
Build tab has no CRM, procurement, or operator source.
Gaps
Next test
Map target operator, economic buyer, and procurement trigger.
Defensibility
missing
Current read
Defensibility signals are missing.
Evidence
No defensibility receipt attached.
Gaps
Next test
Refresh defensibility bars with source receipts.
Integration burden
missing
Current read
No public implementation surface observed.
Evidence
No GitHub or Hugging Face payload attached.
Gaps
Next test
Write integration checklist from prototype path and target workflow.
Capital intensity
missing
Current read
No observed cost estimate is verified.
Evidence
Cost passport has no observed_usd value.
Gaps
Next test
Run cost passport or mark the cost field not applicable.
Regulatory load
missing
Current read
No regulatory classification is attached.
Evidence
Build Passport ledger does not include regulatory flags.
Gaps
Next test
Classify regulatory flags before commercialization planning.
No named scientific founder assigned.
Paper authors are not treated as operators without consent.
People
No named person assigned.
Gaps
Next verification path
Prototype owner missing.
Build Passport does not name an implementer.
People
No named person assigned.
Gaps
Next verification path
Operator workflow not sourced.
No buyer or workflow interview attached.
People
No named person assigned.
Gaps
Next verification path
No GTM owner verified.
No CRM or outreach source attached.
People
No named person assigned.
Gaps
Next verification path
Regulatory need unclassified.
No clinical or regulatory source attached.
People
No named person assigned.
Gaps
Next verification path
ARTIFACTS
No public artifacts yet.
DEFENSIBILITY
Defensibility and confidence evidence pending.
WATCHTOWER
No verified watchtower monitor rows yet.
FORESIGHT
No prediction yet — minted on next Foresight batch.
OPPORTUNITYKERNEL CHANGES SINCE LAST VIEW
No verified OpportunityKernel changes since the last view.
COMPETITIVE LANDSCAPE UPDATES
No verified competitive landscape changes yet.
RELATED PAPER UPDATES
No verified related paper changes yet.
SIGNAL CANVAS HISTORY AND DELTAS
No Signal Canvas history deltas yet.
TIMELINE
Save this paper to start tracking momentum - commits, demos, and score changes appear here.
No tracked events yet.
Score trend will appear after multiple data points.
BUZZ
Buzz trend pending.